Table 3.

Effect of HBAO on plasma glucose level (mg/dl) and glycosylated hemoglobin (A1c) (in percentages) level in normal control and STZ-induced diabetic treated rats.

Groups	Plasma glucose level at different periods of time in normal control and STZ-induced diabetic treated rats			Glycosylated Hemoglobin (A1c) (%) at the end of therapy
	At start of therapy	On 22nd day of therapy	At the end of therapy (on 45th day)
Group 1	93.78±1.03	96.45±1.003	97.80±1.61	7.09±0.02
Group 2	92.64±0.86	93.54±0.93	94.34±1.34	7.13±0.02
Group 3	290.6±1.13a	294.5±1.22a	326.9±1.6a	12.51±0.15a
Group 4	286.4±1.17	265.4±0.87	244.5±0.98	11.52±0.13
Group 5	284±0.7	244.2±2.14	153.8±1.42*	9.606±0.12*
Group 6	282±0.66	206.1±0.75	114.7±1.46*	8.42±0.18**
Group 7	280.3±0.7	197.6±1.14	104.3±1.66*	7.46±0.18***

The data are expressed as mean ± SEM. The comparisons were made by one way ANOVA followed by Dunnett’s test.

^*p<0.05 is considered significant when compared to the control group (0 h)

^**p<0.001 is considered very significant when compared to the control group (0 h)

^***p<0.001 is considered extremely significant when compared to the control group (0 h).

^a– compared to normal; * – compared to diabetic control